Skip to main content
. 2023 Nov 16;109(8):2542–2554. doi: 10.3324/haematol.2023.283917

Table 2.

Clinical and hematologic features of patients with SH2B3-mutated juvenile myelomonocytic leukemia (JMML) in comparison with patients with Noonan syndrome-JMML47 (Strullu et al., updated) and with the whole French JMML cohort (excluding patients with Noonan syndrome).

graphic file with name 1092542.tab2.jpg